IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v13y2022i1d10.1038_s41467-022-32255-7.html
   My bibliography  Save this article

Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasis

Author

Listed:
  • Michael Papanicolaou

    (The Garvan Institute of Medical Research and The Kinghorn Cancer Centre
    University of Technology Sydney
    Garvan Institute of Medical Research)

  • Amelia L. Parker

    (The Garvan Institute of Medical Research and The Kinghorn Cancer Centre
    Garvan Institute of Medical Research
    UNSW Sydney)

  • Michelle Yam

    (The Garvan Institute of Medical Research and The Kinghorn Cancer Centre
    Garvan Institute of Medical Research)

  • Elysse C. Filipe

    (The Garvan Institute of Medical Research and The Kinghorn Cancer Centre
    Garvan Institute of Medical Research
    UNSW Sydney)

  • Sunny Z. Wu

    (The Garvan Institute of Medical Research and The Kinghorn Cancer Centre
    Garvan Institute of Medical Research
    UNSW Sydney)

  • Jessica L. Chitty

    (The Garvan Institute of Medical Research and The Kinghorn Cancer Centre
    Garvan Institute of Medical Research
    UNSW Sydney)

  • Kaitlin Wyllie

    (The Garvan Institute of Medical Research and The Kinghorn Cancer Centre
    Garvan Institute of Medical Research)

  • Emmi Tran

    (The Garvan Institute of Medical Research and The Kinghorn Cancer Centre
    Garvan Institute of Medical Research)

  • Ellie Mok

    (The Garvan Institute of Medical Research and The Kinghorn Cancer Centre
    Garvan Institute of Medical Research)

  • Audrey Nadalini

    (The Garvan Institute of Medical Research and The Kinghorn Cancer Centre
    Garvan Institute of Medical Research)

  • Joanna N. Skhinas

    (The Garvan Institute of Medical Research and The Kinghorn Cancer Centre
    Garvan Institute of Medical Research)

  • Morghan C. Lucas

    (The Garvan Institute of Medical Research and The Kinghorn Cancer Centre)

  • David Herrmann

    (The Garvan Institute of Medical Research and The Kinghorn Cancer Centre
    Garvan Institute of Medical Research
    UNSW Sydney)

  • Max Nobis

    (The Garvan Institute of Medical Research and The Kinghorn Cancer Centre
    Garvan Institute of Medical Research
    UNSW Sydney)

  • Brooke A. Pereira

    (The Garvan Institute of Medical Research and The Kinghorn Cancer Centre
    Garvan Institute of Medical Research
    UNSW Sydney)

  • Andrew M. K. Law

    (The Garvan Institute of Medical Research and The Kinghorn Cancer Centre)

  • Lesley Castillo

    (The Garvan Institute of Medical Research and The Kinghorn Cancer Centre)

  • Kendelle J. Murphy

    (The Garvan Institute of Medical Research and The Kinghorn Cancer Centre
    Garvan Institute of Medical Research
    UNSW Sydney)

  • Anaiis Zaratzian

    (The Garvan Institute of Medical Research and The Kinghorn Cancer Centre)

  • Jordan F. Hastings

    (The Garvan Institute of Medical Research and The Kinghorn Cancer Centre)

  • David R. Croucher

    (The Garvan Institute of Medical Research and The Kinghorn Cancer Centre
    UNSW Sydney)

  • Elgene Lim

    (The Garvan Institute of Medical Research and The Kinghorn Cancer Centre
    UNSW Sydney)

  • Brian G. Oliver

    (University of Technology Sydney
    The University of Sydney)

  • Fatima Valdes Mora

    (Children’s Cancer Institute
    UNSW Sydney)

  • Benjamin L. Parker

    (University of Sydney)

  • David Gallego-Ortega

    (The Garvan Institute of Medical Research and The Kinghorn Cancer Centre
    UNSW Sydney
    University of Technology Sydney)

  • Alexander Swarbrick

    (The Garvan Institute of Medical Research and The Kinghorn Cancer Centre
    Garvan Institute of Medical Research
    UNSW Sydney)

  • Sandra O’Toole

    (The Garvan Institute of Medical Research and The Kinghorn Cancer Centre
    UNSW Sydney
    Royal Prince Alfred Hospital and NSW Health Pathology)

  • Paul Timpson

    (The Garvan Institute of Medical Research and The Kinghorn Cancer Centre
    Garvan Institute of Medical Research
    UNSW Sydney)

  • Thomas R. Cox

    (The Garvan Institute of Medical Research and The Kinghorn Cancer Centre
    Garvan Institute of Medical Research
    UNSW Sydney)

Abstract

The tumour stroma, and in particular the extracellular matrix (ECM), is a salient feature of solid tumours that plays a crucial role in shaping their progression. Many desmoplastic tumours including breast cancer involve the significant accumulation of type I collagen. However, recently it has become clear that the precise distribution and organisation of matrix molecules such as collagen I is equally as important in the tumour as their abundance. Cancer-associated fibroblasts (CAFs) coexist within breast cancer tissues and play both pro- and anti-tumourigenic roles through remodelling the ECM. Here, using temporal proteomic profiling of decellularized tumours, we interrogate the evolving matrisome during breast cancer progression. We identify 4 key matrisomal clusters, and pinpoint collagen type XII as a critical component that regulates collagen type I organisation. Through combining our proteomics with single-cell transcriptomics, and genetic manipulation models, we show how CAF-secreted collagen XII alters collagen I organisation to create a pro-invasive microenvironment supporting metastatic dissemination. Finally, we show in patient cohorts that collagen XII may represent an indicator of breast cancer patients at high risk of metastatic relapse.

Suggested Citation

  • Michael Papanicolaou & Amelia L. Parker & Michelle Yam & Elysse C. Filipe & Sunny Z. Wu & Jessica L. Chitty & Kaitlin Wyllie & Emmi Tran & Ellie Mok & Audrey Nadalini & Joanna N. Skhinas & Morghan C. , 2022. "Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasis," Nature Communications, Nature, vol. 13(1), pages 1-21, December.
  • Handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-32255-7
    DOI: 10.1038/s41467-022-32255-7
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-022-32255-7
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-022-32255-7?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Claire Vennin & Pauline Mélénec & Romain Rouet & Max Nobis & Aurélie S. Cazet & Kendelle J. Murphy & David Herrmann & Daniel A. Reed & Morghan C. Lucas & Sean C. Warren & Zehra Elgundi & Mark Pinese &, 2019. "CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan," Nature Communications, Nature, vol. 10(1), pages 1-22, December.
    2. Xiujie Sun & Bogang Wu & Huai-Chin Chiang & Hui Deng & Xiaowen Zhang & Wei Xiong & Junquan Liu & Aaron M. Rozeboom & Brent T. Harris & Eline Blommaert & Antonio Gomez & Roderic Espin Garcia & Yufan Zh, 2021. "Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion," Nature, Nature, vol. 599(7886), pages 673-678, November.
    3. Chenxi Tian & Ying Huang & Karl R. Clauser & Steffen Rickelt & Allison N. Lau & Steven A. Carr & Matthew G. Vander Heiden & Richard O. Hynes, 2021. "Suppression of pancreatic ductal adenocarcinoma growth and metastasis by fibrillar collagens produced selectively by tumor cells," Nature Communications, Nature, vol. 12(1), pages 1-16, December.
    4. David H. Peng & Bertha Leticia Rodriguez & Lixia Diao & Limo Chen & Jing Wang & Lauren A. Byers & Ying Wei & Harold A. Chapman & Mitsuo Yamauchi & Carmen Behrens & Gabriela Raso & Luisa Maren Solis So, 2020. "Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion," Nature Communications, Nature, vol. 11(1), pages 1-18, December.
    5. Aurélie S. Cazet & Mun N. Hui & Benjamin L. Elsworth & Sunny Z. Wu & Daniel Roden & Chia-Ling Chan & Joanna N. Skhinas & Raphaël Collot & Jessica Yang & Kate Harvey & M. Zahied Johan & Caroline Cooper, 2018. "Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer," Nature Communications, Nature, vol. 9(1), pages 1-18, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Wenfeng Ren & Zilong Xu & Yating Chang & Fei Ju & Hongning Wu & Zhiqi Liang & Min Zhao & Naizhen Wang & Yanhua Lin & Chenhang Xu & Shengming Chen & Yipeng Rao & Chaolong Lin & Jianxin Yang & Pingguo L, 2024. "Pharmaceutical targeting of OTUB2 sensitizes tumors to cytotoxic T cells via degradation of PD-L1," Nature Communications, Nature, vol. 15(1), pages 1-20, December.
    2. Sandrine Vadon-Le Goff & Agnès Tessier & Manon Napoli & Cindy Dieryckx & Julien Bauer & Mélissa Dussoyer & Priscillia Lagoutte & Célian Peyronnel & Lucie Essayan & Svenja Kleiser & Nicole Tueni & Emma, 2023. "Identification of PCPE-2 as the endogenous specific inhibitor of human BMP-1/tolloid-like proteinases," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    3. Stefanie Hiltbrunner & Lena Cords & Sabrina Kasser & Sandra N. Freiberger & Susanne Kreutzer & Nora C. Toussaint & Linda Grob & Isabelle Opitz & Michael Messerli & Martin Zoche & Alex Soltermann & Mar, 2023. "Acquired resistance to anti-PD1 therapy in patients with NSCLC associates with immunosuppressive T cell phenotype," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    4. Kuo-Sheng Hsu & James M. Dunleavey & Christopher Szot & Liping Yang & Mary Beth Hilton & Karen Morris & Steven Seaman & Yang Feng & Emily M. Lutz & Robert Koogle & Francesco Tomassoni-Ardori & Saurabh, 2022. "Cancer cell survival depends on collagen uptake into tumor-associated stroma," Nature Communications, Nature, vol. 13(1), pages 1-18, December.
    5. Masud, M.A. & Kim, Eunjung, 2024. "Theoretical understanding of evolutionary dosing following tumor dynamics," Chaos, Solitons & Fractals, Elsevier, vol. 179(C).
    6. Qi Zhang & Rober Abdo & Cristiana Iosef & Tomonori Kaneko & Matthew Cecchini & Victor K. Han & Shawn Shun-Cheng Li, 2022. "The spatial transcriptomic landscape of non-small cell lung cancer brain metastasis," Nature Communications, Nature, vol. 13(1), pages 1-19, December.
    7. Karl Smith-Byrne & Åsa Hedman & Marios Dimitriou & Trishna Desai & Alexandr V. Sokolov & Helgi B. Schioth & Mine Koprulu & Maik Pietzner & Claudia Langenberg & Joshua Atkins & Ricardo Cortez Penha & J, 2024. "Identifying therapeutic targets for cancer among 2074 circulating proteins and risk of nine cancers," Nature Communications, Nature, vol. 15(1), pages 1-11, December.
    8. Hugo Croizer & Rana Mhaidly & Yann Kieffer & Geraldine Gentric & Lounes Djerroudi & Renaud Leclere & Floriane Pelon & Catherine Robley & Mylene Bohec & Arnaud Meng & Didier Meseure & Emanuela Romano &, 2024. "Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer," Nature Communications, Nature, vol. 15(1), pages 1-28, December.
    9. Hongjuan Yao & Wenping Song & Rui Cao & Cheng Ye & Li Zhang & Hebing Chen & Junting Wang & Yuchen Shi & Rui Li & Yi Li & Xiujun Liu & Xiaofei Zhou & Rongguang Shao & Liang Li, 2022. "An EGFR/HER2-targeted conjugate sensitizes gemcitabine-sensitive and resistant pancreatic cancer through different SMAD4-mediated mechanisms," Nature Communications, Nature, vol. 13(1), pages 1-24, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-32255-7. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.